Biarylcarboxylic acids and -amides: inhibition of phosphodiesterase type IV versus [3H]rolipram binding activity and their relationship to emetic behavior in the ferret.
@article{Duplantier1996BiarylcarboxylicAA, title={Biarylcarboxylic acids and -amides: inhibition of phosphodiesterase type IV versus [3H]rolipram binding activity and their relationship to emetic behavior in the ferret.}, author={A. Duplantier and M. S. Biggers and R. J. Chambers and J. Cheng and K. Cooper and D. Damon and J. F. Eggler and K. Kraus and A. Marfat and H. Masamune and J. Pillar and J. T. Shirley and J. Umland and J. W. Watson}, journal={Journal of medicinal chemistry}, year={1996}, volume={39 1}, pages={ 120-5 } }
In addition to having desirable inhibitory effects on inflammation, anaphylaxis, and smooth muscle contraction, PDE-IV inhibitors also produce undesirable side effects including nausea and vomiting. In general, compounds that inhibit PDE-IV also potently displace [3H]rolipram from a high-affinity binding site in rat cortex. While this binding site has not been identified, it has been proposed to be an allosteric binding site on the PDE-IV enzyme. Preliminary studies have suggested that the… Expand
Topics from this paper
123 Citations
Phosphodiesterase 4 conformers: preparation of recombinant enzymes and assay for inhibitors.
- Chemistry, Medicine
- Analytical biochemistry
- 1999
- 13
Correlation between emetic effect of phosphodiesterase 4 inhibitors and their occupation of the high-affinity rolipram binding site in Suncus murinus brain.
- Medicine, Chemistry
- European journal of pharmacology
- 2007
- 27
Proposal for pharmacologically distinct conformers of PDE4 cyclic AMP phosphodiesterases.
- Chemistry, Medicine
- Cellular signalling
- 1997
- 164
Emesis induced by inhibitors of type IV cyclic nucleotide phosphodiesterase (PDE IV) in the ferret
- Chemistry, Medicine
- Neuropharmacology
- 1999
- 78
Anti-inflammatory activities of a new series of selective phosphodiesterase 4 inhibitors derived from 9-benzyladenine.
- Chemistry, Medicine
- The Journal of pharmacology and experimental therapeutics
- 2000
- 36
- PDF
Anti-Inflammatory Activities of a New Series of Selective Phosphodiesterase 4 Inhibitors Derived from 9-Benzyladenine 1
- 2000
- 1
- Highly Influenced
- PDF
A novel phosphodiesterase type 4 inhibitor, YM976 (4-(3-chlorophenyl)-1,7-diethylpyrido[2,3-d]pyrimidin-2(1H)-one), with little emetogenic activity.
- Chemistry, Medicine
- The Journal of pharmacology and experimental therapeutics
- 2000
- 42
- PDF
Inhibitor Binding to Type 4 Phosphodiesterase (PDE4) Assessed Using [3H]Piclamilast and [3H]Rolipram
- Chemistry
- Journal of Pharmacology and Experimental Therapeutics
- 2003
- 30
Differential effects of PDE4 inhibitors on cortical neurons and T-lymphocytes.
- Medicine, Chemistry
- Journal of pharmacological sciences
- 2008
- 7
Highly potent PDE4 inhibitors with therapeutic potential.
- Chemistry, Medicine
- Bioorganic & medicinal chemistry
- 2004
- 12